{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02351128","recordId":"NCT02351128","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02351128-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02351128.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02351128.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-01-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2015-01-29","publishedAt":"2026-08-23","recordId":"NCT02351128","recordSha256":"fd04edc5789c7210f5e7c86aa9bd4d1c52dc4de102c0d4a6b793b1c84f02636d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351128?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-08-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2015-08-11","publishedAt":"2026-08-23","recordId":"NCT02351128","recordSha256":"bbdc02dcc1326c9f4fc5fa94884fd9053fcaf46d0ae1becf77ccac53280b2fd5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351128?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2016-05-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2016-05-31","publishedAt":"2026-08-23","recordId":"NCT02351128","recordSha256":"80045bd450d55b79877b056417aea132c8fc509e11e2316dde4e43f44156e4b5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351128?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2017-02-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-02-21","publishedAt":"2026-08-23","recordId":"NCT02351128","recordSha256":"6f7745417814008a5f899740884a22eda0f1a323fcb695b03b2caff10ffb50ea","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351128?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2017-10-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2017-10-17","publishedAt":"2026-08-23","recordId":"NCT02351128","recordSha256":"192f209863033916afa6d00b5b75cdcc7f615d4d4582096cc08d8d89dfb99e1e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351128?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"630735145d43e42b7e5226bcc71a53b344f10779f48080c23daf1eed32e0f7b6"}}